10-Q: Antiaging Quantum Living Inc. Reports Increased Revenue but Widening Losses in Q2 2025

Sentiment:

Quarterly Report


Antiaging Quantum Living Inc. saw a significant increase in revenue but also a substantial rise in net losses for the quarter ended September 30, 2024, compared to the same period last year.

Worse than expectedThe company's net loss increased significantly compared to the same period last year.The company's cash reserves decreased substantially.The company's working capital deficit increased.

Summary

  • Antiaging Quantum Living Inc. reported a revenue of $375,243 for the six months ended September 30, 2024, a significant increase from $1,200 in the same period of 2023.
  • The company's operating expenses also increased substantially to $772,406 for the six months ended September 30, 2024, compared to $55,305 in the same period of 2023.
  • The net loss for the six months ended September 30, 2024, was $411,654, a considerable increase from the net loss of $54,105 for the same period in 2023.
  • The company's cash and cash equivalents decreased to $37,403 as of September 30, 2024, from $166,552 as of March 31, 2024.
  • The company has a working capital deficit of $986,427 as of September 30, 2024, compared to a deficit of $647,227 as of March 31, 2024.
  • The company's accumulated deficit increased to $1,100,957 as of September 30, 2024, from $689,303 as of March 31, 2024.
  • The company's liabilities are primarily funded by shareholder loans, which do not require immediate repayment.

Sentiment

Score: 3

Explanation: The document highlights significant revenue growth but is overshadowed by substantial losses, a concerning cash position, and doubts about the company's ability to continue as a going concern. The sentiment is negative due to the financial instability and internal control weaknesses.

Positives

  • The company experienced a substantial increase in revenue, primarily from sales of health and beauty products and online platform technical support services.
  • The company has secured loans from related parties for working capital, indicating continued support from its shareholders.
  • The company has expanded its business operations by establishing several subsidiaries in Hong Kong and China.

Negatives

  • The company's net loss has significantly increased due to higher operating expenses.
  • The company's cash reserves have decreased substantially.
  • The company has a significant working capital deficit.
  • The company has a large accumulated deficit.
  • The company's disclosure controls and procedures were deemed not effective due to material weaknesses in internal control over financial reporting.

Risks

  • The company's ability to continue as a going concern is in doubt due to negative financial trends, including cash outflow from operating activities, operating losses, and an accumulated deficit.
  • The company's reliance on shareholder loans for funding poses a risk if such funding is not available in the future.
  • The company's internal control weaknesses could lead to inaccurate financial reporting.
  • The company operates in a competitive and rapidly changing environment, which could impact its future performance.

Future Outlook

The company's management plans to improve business profitability, generate sufficient cash flow, and obtain additional working capital funds from the majority shareholder to meet its operating needs. However, there is no assurance that these plans will be sufficient.

Management Comments

  • Management is committed to implementing expense control measures in the near term to support liquidity.
  • The shareholders are prepared to continue providing funding as needed.

Industry Context

The company's expansion into healthcare management and insurance services reflects a broader trend of companies diversifying into the growing healthcare sector. The company's focus on e-commerce platforms and online advertising aligns with the increasing importance of digital channels in the health and wellness industry.

Comparison to Industry Standards

  • The company's significant increase in revenue, while positive, is offset by a substantial increase in operating expenses and net losses, which is not typical for established companies in the health and wellness sector.
  • The company's negative working capital and accumulated deficit are concerning and indicate a need for significant financial restructuring or capital infusion.
  • Compared to other companies in the e-commerce and online advertising space, Antiaging Quantum Living Inc. is still in an early stage of development and faces significant challenges in achieving profitability.
  • The company's reliance on related party loans is not uncommon for early-stage companies but may raise concerns about financial independence and long-term sustainability.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer, Chief Financial Officer, President and DirectorMs. Jing WanMr. Barry Wan2023-06-16Ms. Jing Wan resigned.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Change in independent registered public accounting firmJ&S Associate PLT was appointed as the new independent registered public accounting firm, replacing PWN LLP.2024-07-25This change addresses a vacancy and is a standard corporate governance procedure.
Increase in authorized sharesThe company increased its authorized shares of common stock from 30,000,000 to 6,000,000,000.2024-09-06This increase provides the company with greater flexibility for future capital raising activities.

Related Party Transactions

  • The company borrowed $157,745 from Tairan Baohe Insurance Sales Co., Ltd., an entity where Mr. Wan's spouse is a shareholder.
  • The outstanding amount due to Mr. Wan was $280,907 as of September 30, 2024.
  • The outstanding amount due to Tairan was $484,462 as of September 30, 2024.

Stakeholder Impact

  • Shareholders face increased risk due to the company's financial instability and going concern issues.
  • Employees may be concerned about the company's ability to continue operations and maintain employment.
  • Customers may be affected by potential disruptions in service or product availability.
  • Suppliers may face increased risk of non-payment due to the company's financial difficulties.
  • Creditors face increased risk of non-repayment due to the company's financial difficulties.

Next Steps

  • The company plans to improve its business profitability.
  • The company plans to generate sufficient cash flow from its operations.
  • The company plans to obtain additional working capital funds from the majority shareholder.

Key Dates

DateDescription
2008-01-01Date referenced in the document, but not a key date for the company.
2014-12-29Antiaging Quantum Living Inc. was incorporated.
2019-06-29Date referenced in the document, but not a key date for the company.
2019-07-01Change of control of the company with Dazhong 368 Inc.
2019-08-01Date referenced in the document, but not a key date for the company.
2021-04-01Date referenced in the document, but not a key date for the company.
2021-05-01Date referenced in the document, but not a key date for the company.
2021-12-28Date referenced in the document, but not a key date for the company.
2022-04-01Date referenced in the document, but not a key date for the company.
2023-03-28The company amended its article with New York State to change the authorized common shares.
2023-04-09Date referenced in the document, but not a key date for the company.
2023-04-10Mr. Barry Wan acquired control of the company and Mr. Dingshan Zhang resigned from all positions.
2023-06-14The company was renamed Antiaging Quantum Living Inc.
2023-06-16Mr. Barry Wan consented to act as the new CEO and CFO.
2023-11-13Antiaging Doctor Hangzhou Holding LTD was incorporated.
2023-11-30Dao Ling Doctor (Zhejiang) Health Management Limited was incorporated.
2023-12-06Dao Ling Doctor (Huzhou) Health Management Limited was incorporated.
2024-06-05Date referenced in the document, but not a key date for the company.
2024-06-06The company amended its article with New York State to increase the authorized shares of common stock.
2024-07-25The Board of Directors approved the appointment of J&S Associate PLT as the new independent registered public accounting firm.
2024-09-06Holders of a majority of the issued and outstanding voting securities of the Company approved an amendment to its Certificate of Incorporation.
2024-09-30End of the reporting period for this quarterly report.
2024-11-14Date of the report.

Keywords

financial results, quarterly report, revenue, net loss, operating expenses, working capital, going concern, internal controls, health and beauty products, online advertising, technical support services

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.